-transparent.png){kind=logo}
Daily administration of 900 mg dihydroxydibutylether (DHBE) produced a significant reduction of lithogenic index in patients with cholesterol gallstones. After treatment with placebo, in the same subjects the lithogenic index rises significantly. The activity of DHBE is not casual.
Related Publications
G Missale, and
E Camarri, and
F Fici, and
A Agosti, and
R Di Murro
January 1983,
International journal of clinical pharmacology, therapy, and toxicology,
G Missale, and
E Camarri, and
F Fici, and
A Agosti, and
R Di Murro
February 1983,
International journal of clinical pharmacology, therapy, and toxicology,
G Missale, and
E Camarri, and
F Fici, and
A Agosti, and
R Di Murro
July 1976,
Fukuoka igaku zasshi = Hukuoka acta medica,
G Missale, and
E Camarri, and
F Fici, and
A Agosti, and
R Di Murro
December 1972,
The Journal of clinical investigation,
G Missale, and
E Camarri, and
F Fici, and
A Agosti, and
R Di Murro
January 1977,
Surgical forum,
G Missale, and
E Camarri, and
F Fici, and
A Agosti, and
R Di Murro
September 1983,
Journal of the National Cancer Institute,
G Missale, and
E Camarri, and
F Fici, and
A Agosti, and
R Di Murro
June 1982,
The American journal of gastroenterology,
G Missale, and
E Camarri, and
F Fici, and
A Agosti, and
R Di Murro
February 1973,
Gut,
G Missale, and
E Camarri, and
F Fici, and
A Agosti, and
R Di Murro
May 1975,
Acta medica Scandinavica,
G Missale, and
E Camarri, and
F Fici, and
A Agosti, and
R Di Murro
December 1973,
Gut,
